834-50-4 Usage
Uses
Used in Pharmaceutical Industry:
Bicyclo[2.2.2]octane-1,4-dicarboxylic acid, Monoethyl ester is used as a key intermediate in the synthesis of various pharmaceuticals for its unique bicyclic structure and reactivity, contributing to the development of novel drugs with improved therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, Bicyclo[2.2.2]octane-1,4-dicarboxylic acid, Monoethyl ester is utilized as a precursor in the production of agrochemicals, such as pesticides and herbicides, due to its ability to enhance the effectiveness and selectivity of these compounds.
Used in Advanced Materials:
Bicyclo[2.2.2]octane-1,4-dicarboxylic acid, Monoethyl ester is employed as a building block in the development of advanced materials, including polymers and composites, leveraging its unique structural features to impart desirable properties such as enhanced stability, strength, and functionality.
Overall, Bicyclo[2.2.2]octane-1,4-dicarboxylic acid, Monoethyl ester is a multifaceted chemical compound with a broad spectrum of applications across different industries, making it an essential component in the field of organic synthesis and product manufacturing.
Check Digit Verification of cas no
The CAS Registry Mumber 834-50-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 8,3 and 4 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 834-50:
(5*8)+(4*3)+(3*4)+(2*5)+(1*0)=74
74 % 10 = 4
So 834-50-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H18O4/c1-2-16-10(15)12-6-3-11(4-7-12,5-8-12)9(13)14/h2-8H2,1H3,(H,13,14)
834-50-4Relevant articles and documents
Design, synthesis, radiolabeling, and in vitro and in vivo evaluation of bridgehead iodinated analogues of N -{2-[4-(2-methoxyphenyl)piperazin-1-yl] ethyl}- N -(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as potential SPECT ligands for the 5-HT1A receptor
Al Hussainy, Rana,Verbeek, Joost,Van Der Born, Dion,Braker, Anton H.,Leysen, Josée E.,Knol, Remco J.,Booij, Jan,Herscheid
supporting information; experimental part, p. 3480 - 3491 (2011/07/07)
Here we describe the design, synthesis, and pharmacological profile of 5-HT1A receptor ligands related to 1 (WAY-100635). The cyclohexyl moiety in 1 and its O-desmethylated analogue 3 were replaced by the bridgehead iodinated bridge-fused rings: adamantyl, cubyl, bicyclo[2.2.2]octyl, or bicyclo[2.2.1]heptyl. All analogues displayed a (sub)nanomolar affinity for the 5-HT1A receptor in vitro. Compounds 6b and 7b appeared to be selective for this receptor over other relevant receptors and could easily be iodinated with radioactive iodine-123. In humane hepatocytes, [ 123I]6b showed a low propensity for amide hydrolysis and a stable carbon-iodine bond. The biodistribution of [123I]6b and [ 123I]7b in rats revealed that the carbon-iodine bond was also stable in vivo. Unfortunately, the brain uptake and the specificity for both radioligands were significantly lower than those of the parent molecule 1. In conclusion, the designed tracers are not suitable for SPECT imaging.